129
Views
0
CrossRef citations to date
0
Altmetric
CORRIGENDUM

Sequential Therapy of Linezolid and Contezolid to Treat Vancomycin-Resistant Enterococcus faecium Pneumonia in a Centenarian Patient: Case Report [Corrigendum]

Pages 1751-1752 | Received 24 Mar 2023, Accepted 24 Mar 2023, Published online: 27 Mar 2023
This article refers to:
Sequential Therapy of Linezolid and Contezolid to Treat Vancomycin-Resistant Enterococcus faecium Pneumonia in a Centenarian Patient: Case Report

Chen P, An L, Zhang Z. Infect Drug Resist. 2023;16:1573–1578.

Page 1575, paragraph two, line 10, the text “(600 mg IV q12d)” should read “(600 mg IV q12h)”.

Page 1575, paragraph two, line 12, the text “(400 mg PO q12d)” should read “(400 mg PO q12h)”.

Page 1576, paragraph five, line three, the text “contezolid 400 mg q12d” should read “contezolid 400 mg q12h”.

Page 1576, paragraph five, line six, the text “recommended dose of 800 mg q12d” should read “recommended dose of 800 mg q12h”.

The authors apologize for these errors and any confusion it may have caused the reader.